Ekadharma International Tbk Net Assets

Latest as of December 2025: Rp1.26 Trillion IDR ≈ $73.81 Million USD

Ekadharma International Tbk net assets. Based on the latest financial reports, Ekadharma International Tbk (EKAD) has net assets worth Rp1.26 Trillion IDR (≈ $73.81 Million USD) as of December 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (Rp1.37 Trillion ≈ $80.48 Million USD) and total liabilities (Rp113.92 Billion ≈ $6.68 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Also explore Ekadharma International Tbk net asset momentum to track the company's year-over-year net asset growth rate.

Key Net Assets Metrics

Metric	Value
Current Net Assets	Rp1.26 Trillion
% of Total Assets	91.71%
Annual Growth Rate	14.33%
5-Year Change	22.24%
10-Year Change	112.76%
Growth Volatility	20.26

Net Assets of Ekadharma International Tbk (2000–2025)

Net assets of Ekadharma International Tbk from 2000 to 2025. This chart illustrates how Ekadharma International Tbk's net assets have evolved over time, based on quarterly financial data. See Ekadharma International Tbk balance sheet quality to measure how much of total assets are equity-financed.

Annual Net Assets for Ekadharma International Tbk (2000–2025)

The table below shows the annual net assets of Ekadharma International Tbk from 2000 to 2025. For live market cap and overall valuation, see Ekadharma International Tbk (EKAD) total market value.

Year	Net Assets	Change
2025-12-31	Rp1.26 Trillion ≈ $73.81 Million	+5.69%
2024-12-31	Rp1.19 Trillion ≈ $69.83 Million	+3.83%
2023-12-31	Rp1.15 Trillion ≈ $67.25 Million	+3.14%
2022-12-31	Rp1.11 Trillion ≈ $65.21 Million	+8.00%
2021-12-31	Rp1.03 Trillion ≈ $60.38 Million	+8.19%
2020-12-31	Rp952.36 Billion ≈ $55.80 Million	+11.71%
2019-12-31	Rp852.54 Billion ≈ $49.96 Million	+17.66%
2018-12-31	Rp724.58 Billion ≈ $42.46 Million	+9.32%
2017-12-31	Rp662.82 Billion ≈ $38.84 Million	+11.96%
2016-12-31	Rp592.00 Billion ≈ $34.69 Million	+102.77%
2015-12-31	Rp291.96 Billion ≈ $17.11 Million	+8.98%
2014-12-31	Rp267.91 Billion ≈ $15.70 Million	+12.70%
2013-12-31	Rp237.71 Billion ≈ $13.93 Million	+23.82%
2012-12-31	Rp191.98 Billion ≈ $11.25 Million	+30.03%
2011-12-31	Rp147.65 Billion ≈ $8.65 Million	+17.93%
2010-12-31	Rp125.20 Billion ≈ $7.34 Million	+40.81%
2009-12-31	Rp88.91 Billion ≈ $5.21 Million	+11.28%
2008-12-31	Rp79.90 Billion ≈ $4.68 Million	+31.21%
2007-12-31	Rp60.90 Billion ≈ $3.57 Million	+5.11%
2006-12-31	Rp57.94 Billion ≈ $3.39 Million	+5.71%
2005-12-31	Rp54.81 Billion ≈ $3.21 Million	+2.38%
2004-12-31	Rp53.53 Billion ≈ $3.14 Million	+7.52%
2003-12-31	Rp49.79 Billion ≈ $2.92 Million	+2.22%
2002-12-31	Rp48.71 Billion ≈ $2.85 Million	+3.91%
2001-12-31	Rp46.87 Billion ≈ $2.75 Million	+5.80%
2000-12-31	Rp44.30 Billion ≈ $2.60 Million	--

Equity Component Analysis

This analysis shows how different components contribute to Ekadharma International Tbk's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

Retained earnings have grown by 4407.2% over the analyzed period, indicating profitable operations and earnings retention.

Ekadharma International Tbk Net Assets Breakdown (December 2025)

Ekadharma International Tbk net assets breakdown by equity component as of December 2025.

Component	Amount	Percentage
Retained Earnings	Rp786.64 Billion	64.05%
Common Stock	Rp34.94 Billion	2.84%
Other Comprehensive Income	Rp406.51 Billion	33.10%
Other Components	Rp138.49 Million	0.01%
Total Equity	Rp1.23 Trillion	100.00%

Ekadharma International Tbk Competitors by Market Cap

The table below lists competitors of Ekadharma International Tbk ranked by their market capitalization.

Company	Market Cap
Babcock International Group PLC LSE:BAB	$63.49 Million
Genexine Inc KQ:095700	$63.49 Million
Rangdong Light source and Vacuum flask JSC VN:RAL	$63.52 Million
Shanghai Huili Building Materials Co Ltd SHG:900939	$63.52 Million
StoneBridge Acquisition II Corporation NASDAQ:APAC	$63.42 Million
Lion Finance Group PLC LSE:BGEO	$63.37 Million
Games Workshop Group PLC LSE:GAW	$63.35 Million
Gold Terra Resource Corp V:YGT	$63.33 Million

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Ekadharma International Tbk's equity between the two most recent reporting periods.

Equity Growth Insights

From 2024 to 2025, total equity changed from 1,159,074,823,000 to 1,228,227,492,000, a change of 69,152,669,000 (6.0%).
Net income of 53,024,734,000 contributed positively to equity growth.
Dividend payments of 31,163,424,000 reduced retained earnings.
Other comprehensive income increased equity by 46,059,577,000.

Equity Change Factors (2024 to 2025)

Factor	Impact	Contribution
Net Income	Rp53.02 Billion	+4.32%
Dividends Paid	Rp31.16 Billion	-2.54%
Other Comprehensive Income	Rp46.06 Billion	+3.75%
Other Changes	Rp1.23 Billion	+0.1%
Total Change	Rp-	5.97%

Book Value vs Market Value Analysis

This analysis compares Ekadharma International Tbk's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

Current price-to-book ratio: 0.88x
The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
The price-to-book ratio has decreased from 6.22x to 0.88x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date	Book Value per Share	Market Price	P/B Ratio
2012-12-31	Rp49.83	Rp310.00	x
2013-12-31	Rp62.75	Rp310.00	x
2014-12-31	Rp71.19	Rp310.00	x
2015-12-31	Rp78.09	Rp310.00	x
2016-12-31	Rp163.24	Rp310.00	x
2017-12-31	Rp183.27	Rp310.00	x
2018-12-31	Rp200.46	Rp310.00	x
2019-12-31	Rp236.33	Rp310.00	x
2020-12-31	Rp264.20	Rp310.00	x
2021-12-31	Rp285.71	Rp310.00	x
2022-12-31	Rp309.37	Rp310.00	x
2023-12-31	Rp318.91	Rp310.00	x
2024-12-31	Rp331.74	Rp310.00	x
2025-12-31	Rp351.54	Rp310.00	x

Capital Efficiency Dashboard

This dashboard shows how efficiently Ekadharma International Tbk utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

Current Return on Equity (ROE): 4.32%
The company may be facing challenges in efficiently utilizing shareholder equity.
DuPont Analysis Breakdown:
• Net Profit Margin: 10.01%
• Asset Turnover: 0.39x
• Equity Multiplier: 1.12x
Recent ROE (4.32%) is below the historical average (12.31%), suggesting potential challenges in capital efficiency.

Historical Capital Efficiency Metrics

Year	Return on Equity	Net Profit Margin	Asset Turnover	Equity Multiplier	Economic Value Added
2000	13.89%	7.43%	1.40x	1.33x	Rp1.71 Billion
2001	12.85%	7.44%	1.35x	1.28x	Rp1.32 Billion
2002	12.86%	8.16%	1.31x	1.20x	Rp1.39 Billion
2003	8.72%	5.30%	1.35x	1.22x	Rp-636.64 Million
2004	8.35%	5.62%	1.26x	1.18x	Rp-881.73 Million
2005	9.46%	4.95%	1.39x	1.37x	Rp-295.61 Million
2006	9.96%	5.23%	1.48x	1.29x	Rp-23.83 Million
2007	6.96%	2.88%	1.73x	1.40x	Rp-1.85 Billion
2008	7.80%	2.52%	1.30x	2.39x	Rp-1.30 Billion
2009	23.65%	8.01%	1.24x	2.38x	Rp9.49 Billion
2010	22.99%	9.63%	1.24x	1.92x	Rp13.83 Billion
2011	20.29%	8.03%	1.38x	1.83x	Rp13.38 Billion
2012	20.66%	9.34%	1.41x	1.57x	Rp18.56 Billion
2013	17.72%	9.28%	1.22x	1.57x	Rp16.93 Billion
2014	16.19%	7.65%	1.28x	1.66x	Rp15.40 Billion
2015	17.28%	8.87%	1.36x	1.43x	Rp19.86 Billion
2016	15.40%	15.44%	0.81x	1.23x	Rp30.78 Billion
2017	11.77%	11.71%	0.81x	1.24x	Rp11.32 Billion
2018	10.33%	9.78%	0.87x	1.22x	Rp2.32 Billion
2019	8.93%	9.73%	0.78x	1.17x	Rp-8.80 Billion
2020	10.13%	13.92%	0.62x	1.18x	Rp1.19 Billion
2021	10.46%	16.58%	0.54x	1.17x	Rp4.59 Billion
2022	7.10%	12.49%	0.50x	1.13x	Rp-31.37 Billion
2023	6.46%	13.88%	0.42x	1.12x	Rp-39.48 Billion
2024	5.56%	12.15%	0.41x	1.12x	Rp-51.47 Billion
2025	4.32%	10.01%	0.39x	1.12x	Rp-69.80 Billion

Industry Comparison

This section compares Ekadharma International Tbk's net assets metrics with peer companies in the Specialty Chemicals industry.

Industry Context

Industry: Specialty Chemicals
Average net assets among peers: $1,394,893,374,387
Average return on equity (ROE) among peers: 9.81%

Peer Company Comparison

Company	Net Assets	Return on Equity	Debt-to-Equity	Market Cap
Ekadharma International Tbk (EKAD)	Rp1.26 Trillion	13.89%	0.09x	$63.47 Million
Avia Avian PT Tbk (AVIA)	$9.57 Trillion	14.63%	0.13x	$1.03 Billion
Colorpak Indonesia Tbk (CLPI)	$506.35 Billion	8.47%	0.53x	$28.15 Million
Duta Pertiwi Nusantara Tbk (DPNS)	$120.81 Billion	3.71%	0.19x	$6.01 Million
Lotte Chemical Titan Tbk PT (FPNI)	$165.04 Million	17.24%	1.02x	$116.12 Million
Indo Komoditi Korpora Tbk PT (INCF)	$142.61 Billion	2.63%	3.07x	$4.21 Million
Intanwijaya Internasional Tbk (INCI)	$144.96 Billion	5.52%	0.17x	$9.49 Million
Lautan Luas Tbk (LTLS)	$954.28 Billion	15.28%	2.66x	$71.66 Million
Emdeki Utama Tbk PT (MDKI)	$974.68 Billion	2.83%	0.07x	$25.20 Million
Obm Drilchem PT (OBMD)	$135.30 Billion	18.02%	0.30x	$7.37 Million

About Ekadharma International Tbk

JK:EKAD Indonesia Specialty Chemicals

Market Cap

$63.47 Million

Rp1.08 Trillion IDR

Market Cap Rank

#20780 Global

#363 in Indonesia

Share Price

Rp310.00

Change (1 day)

-1.90%

52-Week Range

Rp153.00 - Rp450.00

All Time High

Rp450.00